For over 20 years, HRA Research has been collecting formulary
data on the monthly activities and decisions of P&T committees from
hospitals across the U.S. Obtained from HRA's proprietary Chief
Pharmacists PanelŪ, the data on all drug classes has been compiled
in HRA's Medical TrendsŪ in Hospital Formulary Committees syndicated
study.
Take advantage of this opportunity to quickly gain current and
historical insight into a single therapeutic class of drugs by purchasing
a portion of HRA's industry leading formulary data set. Leverage
HRA's extensive relationships with hospital pharmacists to cost-effectively
learn from the hard to reach healthcare professionals who make decisions
on your products every day.
|
|
|
|
| |
|
|
|
- AIDS Therapy
- Anesthetic Agents
- Anti-anxiety Agents
- Anti-arthritics
- Anti-asthmatics
- Antiemetics
- Anti-fungals
- Anti-infectives
- Anti-migraines
- Anti-nausants
- Anti-neoplastics
- Anti-pruritics
- Anti-secretory
- Anti-spasmodics
|
- Anti-ulcer
- Anti-virals
- Blood modifiers
- Bronchodialators
- Central Nervous System
- Controlled Analgesics
- Hormones
- Hormone Regulators
- Hypoglycemics
- Hypnotics
- Muscle Relaxants
- Non-narcotic Analgesics
- Pro-motility Agents
- Sedatives
|
|
- Drug Approvals
- Disapprovals
- Deletions
- Tabled Decisions
- Drug Restrictions
- Annual & Historic Formulary Uptake & Status
|
To learn more about HRA's Hospital Formulary Tracking
Data or any of the proprietary research products
within HRA Research's Syndicated service line, please call
(973) 240-1200.
>> Syndicated Research
| 
